Different mechanisms have been reported for inactivation of the p16INK4a gene in GBM, including homozygous deletion and hypermethylation of the promoter region.71–74 In GBM, frequent promoter hypermethylation has been noted for p14ARF and RB1. 75–77. Here, CDKN2A is linked to glioblastoma.